Comments
Loading...

Kiniksa Pharmaceuticals

KNSANASDAQ
Logo brought to you by Benzinga Data
$26.25
0.983.88%
At Close: -
$26.25
00.00%
After Hours: 4:00 PM EDT
15 minutes delayed
Consensus Rating1
Buy
Highest Price Target1
$40.00
Lowest Price Target1
$30.00
Consensus Price Target1
$33.43

Kiniksa Pharmaceuticals (NASDAQ:KNSA) Stock, Analyst Ratings, Price Targets, Forecasts

Kiniksa Pharmaceuticals International PLC has a consensus price target of $33.43 based on the ratings of 7 analysts. The high is $40 issued by Jefferies on September 13, 2024. The low is $30 issued by JP Morgan on May 1, 2024. The 3 most-recent analyst ratings were released by Jefferies, Wedbush, and Wells Fargo on September 13, 2024, July 23, 2024, and May 3, 2024, respectively. With an average price target of $36 between Jefferies, Wedbush, and Wells Fargo, there's an implied 37.14% upside for Kiniksa Pharmaceuticals International PLC from these most-recent analyst ratings.

Analyst Trends and Forecast
1
Apr
2
May
1
Jul
0
0
0
0
Sep
Buy
Hold
Sell
Strong Sell
Analyst Rating and Forecast
12345
4.3
Buy
Strong Buy
Buy
Hold
Sell
Strong Sell

Analyst Firms Making Recommendations1

Jefferies
Wedbush
Wells Fargo
JP Morgan
Evercore ISI Group

1calculated from analyst ratings

Analyst Ratings for Kiniksa Pharmaceuticals

Data brought to you by Benzinga APIs

FAQ

Q

What is the target price for Kiniksa Pharmaceuticals (KNSA) stock?

A

The latest price target for Kiniksa Pharmaceuticals (NASDAQ:KNSA) was reported by Jefferies on September 13, 2024. The analyst firm set a price target for $40.00 expecting KNSA to rise to within 12 months (a possible 52.38% upside). 6 analyst firms have reported ratings in the last year.

Q

What is the most recent analyst rating for Kiniksa Pharmaceuticals (KNSA)?

A

The latest analyst rating for Kiniksa Pharmaceuticals (NASDAQ:KNSA) was provided by Jefferies, and Kiniksa Pharmaceuticals initiated their buy rating.

Q

When was the last upgrade for Kiniksa Pharmaceuticals (KNSA)?

A

There is no last upgrade for Kiniksa Pharmaceuticals

Q

When was the last downgrade for Kiniksa Pharmaceuticals (KNSA)?

A

There is no last downgrade for Kiniksa Pharmaceuticals.

Q

When is the next analyst rating going to be posted or updated for Kiniksa Pharmaceuticals (KNSA)?

A

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Kiniksa Pharmaceuticals, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Kiniksa Pharmaceuticals was filed on September 13, 2024 so you should expect the next rating to be made available sometime around September 13, 2025.

Q

Is the Analyst Rating Kiniksa Pharmaceuticals (KNSA) correct?

A

While ratings are subjective and will change, the latest Kiniksa Pharmaceuticals (KNSA) rating was a initiated with a price target of $0.00 to $40.00. The current price Kiniksa Pharmaceuticals (KNSA) is trading at is $26.25, which is within the analyst’s predicted range.

Browse analyst ratings and price targets on all stocks.

People Also Watch